AVATROMBOPAG for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5 adverse event reports in the FDA FAERS database where AVATROMBOPAG was used for Neoplasm malignant.
Most Reported Side Effects for AVATROMBOPAG
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Platelet count decreased | 268 | 14.8% | 3 | 61 |
| Drug ineffective | 245 | 13.5% | 4 | 26 |
| Headache | 187 | 10.3% | 4 | 21 |
| Platelet count increased | 167 | 9.2% | 1 | 21 |
| Fatigue | 131 | 7.2% | 4 | 17 |
| Off label use | 111 | 6.1% | 12 | 16 |
| Platelet count abnormal | 90 | 5.0% | 0 | 16 |
| Nausea | 81 | 4.5% | 1 | 14 |
| Inappropriate schedule of product administration | 76 | 4.2% | 2 | 12 |
| Product dose omission issue | 75 | 4.1% | 2 | 15 |
| Death | 68 | 3.8% | 68 | 5 |
| Arthralgia | 57 | 3.1% | 3 | 7 |
| Dizziness | 48 | 2.7% | 1 | 1 |
| Asthenia | 47 | 2.6% | 7 | 16 |
| Rash | 44 | 2.4% | 0 | 8 |
Other Indications for AVATROMBOPAG
Immune thrombocytopenia (951)
Thrombocytopenia (340)
Product used for unknown indication (301)
Liver disorder (39)
Platelet count decreased (32)
Hepatic cirrhosis (28)
Immune thrombocytopenic purpura (28)
Aplastic anaemia (22)
Thrombocytopenic purpura (13)
Cirrhosis alcoholic (8)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)